Clinical Trial Update: LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial compared LEO 90100 to calcipotriol plus betamethasone dipropionate ointment and to vehicle controls in adults with psoriasis vulgari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Calcipotriol plus betamethone dipropionate ointment (calcipotriol and betamethasone dipropionate ointment)
• LEO 90100
• LEO 90100 Vehicle
• Ointment Vehicle

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2015-12-09